PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Acer Therapeutics Inc. (ACER)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00444P1084
CUSIP00444P108
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$16.15M
EPS-$1.93
Revenue (TTM)$360.00K
Gross Profit (TTM)$1.26M
EBITDA (TTM)-$19.73M
Year Range$0.55 - $1.76
Target Price$1.50
Short %2.61%
Short Ratio2.87

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACER

Acer Therapeutics Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Acer Therapeutics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%250.00%Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05Nov 12Nov 19Nov 26Dec 03Dec 10Dec 17
-100.00%
248.12%
ACER (Acer Therapeutics Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period


PeriodReturnBenchmark
Year-To-DateN/A7.28%
1 monthN/A2.23%
6 monthsN/A14.98%
1 yearN/A30.65%
5 years (annualized)N/A12.59%
10 years (annualized)N/A10.61%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202347.13%-36.33%3.09%-21.44%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Acer Therapeutics Inc. (ACER) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ACER
Acer Therapeutics Inc.
^GSPC
S&P 500
2.64

Sharpe Ratio


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05Nov 12Nov 19Nov 26Dec 03Dec 10Dec 17
-0.78
1.74
ACER (Acer Therapeutics Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Acer Therapeutics Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05Nov 12Nov 19Nov 26Dec 03Dec 10Dec 17
-100.00%
-0.99%
ACER (Acer Therapeutics Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Acer Therapeutics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Acer Therapeutics Inc. was 100.00%, occurring on Aug 25, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Aug 16, 20004695Aug 25, 2023
-66.67%Apr 25, 20004May 8, 200028Aug 11, 200032
-25%Mar 23, 20001Mar 23, 20002Apr 4, 20003

Volatility

Volatility Chart

The current Acer Therapeutics Inc. volatility is 19.56%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%Sep 24OctoberOct 08Oct 15Oct 22Oct 29Nov 05Nov 12Nov 19Nov 26Dec 03Dec 10Dec 17
19.56%
1.92%
ACER (Acer Therapeutics Inc.)
Benchmark (^GSPC)

Financials

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM2022202120202019
Revenue

Total Revenue

371.79K0.001.26M0.000.00

Cost Of Revenue

83.81K0.000.000.000.00

Gross Profit

287.99K0.001.26M0.000.00
Operating Expenses

Selling, General & Admin Expenses

5.42M12.69M10.70M10.95M16.05M

R&D Expenses

5.38M11.92M6.51M11.85M13.85M

Total Operating Expenses

22.45M24.61M17.21M22.80M29.90M
Income

Income Before Tax

-39.10M-26.24M-15.37M-22.89M-29.42M

Operating Income

-11.75M-24.61M-15.95M-22.80M-29.90M

EBIT

4.28M-24.61M-15.95M-22.80M-29.90M

Earnings From Continuing Operations

-24.37M-26.24M-15.37M-22.89M-29.42M

Net Income

-49.68M-27.86M-14.73M-22.90M-28.88M

Income Tax Expense

15.37M1.62M-645.31K11.81K-537.75K

Interest Expense

1.06M101.43K574.40K0.000.00

Other Non-Operating Income (Expenses)

-26.71M-1.62M574.40K-82.62K479.47K

Extraordinary Items

0.000.000.000.000.00

Discontinued Operations

0.000.000.000.000.00

Effect Of Accounting Charges

0.000.000.000.000.00

Non Recurring

0.000.000.000.000.00

Minority Interest

0.000.000.000.000.00

Other Items

0.000.000.000.000.00
Values in USD except per share items